1. The Autophagy Receptor TAX1BP1 (T6BP) is a novel player in antigen presentation by MHC-II molecules
- Author
-
Clémence Richetta, Kumari A, Cédric Pionneau, Pereira M, Arnaud Moris, Gall Ml, Manoury B, Raphaël Jeger-Madiot, Grégoire S, Faure M, Bertrand L, Sarango G, Stéphanie Graff-Dubois, Stefanović S, Audrey Esclatine, Rosoy E, Michael Ghosh, Ramirez Bc, Institut de Biologie Intégrative de la Cellule (I2BC), and Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS)
- Subjects
0303 health sciences ,CD74 ,Chemistry ,T cell ,media_common.quotation_subject ,[SDV]Life Sciences [q-bio] ,Antigen presentation ,Autophagy ,3. Good health ,Cell biology ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Calnexin ,medicine ,Gene silencing ,Antigen-presenting cell ,Internalization ,030304 developmental biology ,030215 immunology ,media_common - Abstract
CD4+ T lymphocytes play a major role in the establishment and maintenance of immunity. They are activated by antigenic peptides derived from extracellular or newly synthesized (endogenous) proteins presented on the surface of antigen presenting cells (APCs) by the MHC-II molecules. The pathways leading to endogenous MHC-II presentation remain poorly characterized. We demonstrate here that the autophagy receptor, T6BP, influences both autophagy-dependent and -independent endogenous presentation of HIV- and HCMV-derived peptides. By studying the immunopeptidome of MHC-II molecules, we show that T6BP affects both the quantity and quality of peptides presented. T6BP silencing induces the mislocalization of the MHC-II-loading compartments and a rapid degradation of the invariant chain (CD74) without altering the expression and internalization kinetics of MHC-II molecules. We determined the interactome of T6BP, identified calnexin as a T6BP partner and show that CANX cytosolic tail is required for this interaction. Remarkably, calnexin silencing replicates the functional consequences of T6BP silencing: decreased CD4+ T cell activation and exacerbated CD74 degradation. Altogether, we unravel T6BP as a key player of the MHC-II-restricted endogenous presentation pathway and we propose one potential mechanism of action.
- Published
- 2021